Literature DB >> 15486768

Quantitative analyses of mRNA and protein levels of neurotrophin-3 in the rat retina during postnatal development and aging.

Masaaki Seki1, Takeo Fukuchi, Takayuki Tanaka, Hiroyuki Nawa, Nobuyuki Takei, Haruki Abe.   

Abstract

PURPOSE: In this study, we sought to elucidate changes in the levels of neurotrophin-3 (NT-3) in the rat retina throughout postnatal development and aging.
METHODS: We demonstrated NT-3 localization in the retina by immunohistochemistry. Protein and mRNA levels of NT-3 were quantified by enzyme-linked immunosorbant assay and semiquantitative reverse transcriptase-polymerase chain reaction, respectively. NT-3 protein levels were assayed in the various regions of the central nervous system. Age-associated changes in protein and mRNA levels of NT-3 in the retinas were assessed.
RESULTS: NT-3-immunoreactivity localized in the ganglion cell layer, inner nuclear layer, and outer nuclear layer. NT-3 content in the retina was relatively high in the examined regions of the central nervous system. Retinal NT-3 protein levels decreased after eye opening, whereas mRNA levels were constant. Both mRNA and protein levels of NT-3 in the retinas of aged animals remained constant.
CONCLUSIONS: Our observations suggest that NT-3 regulation in the retina is independent of increasing visual stimuli after eye opening. Stable expression of NT-3 in the adult retina suggests a possible role in the maintenance of the retinal environment throughout later life.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486768     DOI: 10.1007/s10384-004-0093-8

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  6 in total

1.  Overexpression of neurotrophin-3 stimulates a second wave of dopaminergic amacrine cell genesis after birth in the mouse retina.

Authors:  Miho Yoshida; Liang Feng; François Grimbert; Krsna V Rangarajan; William Buggele; David R Copenhagen; Jianhua Cang; Xiaorong Liu
Journal:  J Neurosci       Date:  2011-08-31       Impact factor: 6.167

Review 2.  Targets of Neuroprotection in Glaucoma.

Authors:  Shaoqing He; Dorota L Stankowska; Dorette Z Ellis; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  J Ocul Pharmacol Ther       Date:  2017-08-18       Impact factor: 2.671

3.  Results from the Population-Based Gutenberg Health Study Revealing Four Altered Autoantibodies in Retinal Vein Occlusion Patients.

Authors:  Katharina Bell; Vanessa M Beutgen; Stefan Nickels; Katrin Lorenz; Yvonne Scheller; Hisham Elbaz; Tunde Peto; Katharina A Ponto; Andreas Schulz; Philipp S Wild; Thomas Münzel; Karl J Lackner; Irene Schmidtmann; Manfred Beutel; Norbert Pfeiffer; Franz H Grus; Alexander K Schuster
Journal:  J Ophthalmol       Date:  2020-07-29       Impact factor: 1.909

4.  Regulation of neonatal development of retinal ganglion cell dendrites by neurotrophin-3 overexpression.

Authors:  Xiaorong Liu; Michael L Robinson; Ann Marie Schreiber; Vincent Wu; Matthew M Lavail; Jianhua Cang; David R Copenhagen
Journal:  J Comp Neurol       Date:  2009-06-10       Impact factor: 3.215

5.  Hyperglycemia Alters the Protein Levels of Prominin-1 and VEGFA in the Retina of Albino Rats.

Authors:  Shaima M Almasry; Eman K Habib; Rasha A Elmansy; Zeinab A Hassan
Journal:  J Histochem Cytochem       Date:  2017-10-27       Impact factor: 2.479

6.  Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma?

Authors:  Ying Guo; Elaine Johnson; William Cepurna; Lijun Jia; Jennifer Dyck; John C Morrison
Journal:  Exp Eye Res       Date:  2009-08-14       Impact factor: 3.467

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.